{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:55:12Z","timestamp":1785941712161,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25242-7","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:42:43Z","timestamp":1761810163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Uncovering potent natural phytochemicals targeting SARS-COV-2 spike protein variants: molecular dynamics insights"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4563-3154","authenticated-orcid":false,"given":"Tuba","family":"Sevimoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"K\u0131z\u0131lp\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihni Onur","family":"\u00c7al\u0131\u015fkaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rem Nur","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"25242_CR1","unstructured":"WHO. World Health Organization. Coronavirus disease 2019 (COVID-19). Situat. Report, 32. 2019, (2020)."},{"key":"25242_CR2","unstructured":"WHO. COVID-19 cases WHO COVID-19 dashboard. Who (2024)."},{"key":"25242_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.02.001","author":"A Wu","year":"2020","unstructured":"Wu, A. et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe https:\/\/doi.org\/10.1016\/j.chom.2020.02.001 (2020).","journal-title":"Cell Host Microbe"},{"key":"25242_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/11779322211025876","author":"R Gorkhali","year":"2021","unstructured":"Gorkhali, R. et al. Structure and function of major SARS-CoV-2 and SARS-CoV proteins. Bioinform. Biol. Insights https:\/\/doi.org\/10.1177\/11779322211025876 (2021).","journal-title":"Bioinform. Biol. Insights"},{"key":"25242_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0485-4","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Yang, C., Xu, X. F., Xu, W. & Liu, S. W. Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. https:\/\/doi.org\/10.1038\/s41401-020-0485-4 (2020).","journal-title":"Acta Pharmacol. Sin."},{"key":"25242_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"25242_CR7","doi-asserted-by":"publisher","first-page":"e9610","DOI":"10.15252\/msb.20209610","volume":"16","author":"F Hikmet","year":"2020","unstructured":"Hikmet, F. et al. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 16, e9610 (2020).","journal-title":"Mol. Syst. Biol."},{"key":"25242_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju, B. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584, 115\u2013119 (2020).","journal-title":"Nature"},{"key":"25242_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1021\/acsptsci.2c00049","volume":"5","author":"JE Hochuli","year":"2022","unstructured":"Hochuli, J. E. et al. Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents. ACS Pharmacol. Transl. Sci. 5, 468\u2013478 (2022).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"25242_CR10","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1016\/j.vaccine.2021.08.081","volume":"39","author":"JLM Law","year":"2021","unstructured":"Law, J. L. M. et al. SARS-COV-2 recombinant receptor-binding-domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1. Vaccine 39, 5769\u20135779 (2021).","journal-title":"Vaccine"},{"key":"25242_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/v13091882","author":"E Domingo","year":"2021","unstructured":"Domingo, E., Garc\u00eda-Crespo, C., Lobo-Vega, R. & Perales, C. Mutation rates, mutation frequencies, and proofreading-repair activities in rna virus genetics. Viruses https:\/\/doi.org\/10.3390\/v13091882 (2021).","journal-title":"Viruses"},{"key":"25242_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27009","author":"M Tahir","year":"2021","unstructured":"Tahir, M. Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.27009 (2021).","journal-title":"J. Med. Virol."},{"key":"25242_CR13","doi-asserted-by":"publisher","first-page":"18126","DOI":"10.1038\/s41598-021-95822-w","volume":"11","author":"S Sharma","year":"2021","unstructured":"Sharma, S. et al. Emergence and expansion of highly infectious spike protein D614G mutant SARS-CoV-2 in central India. Sci. Rep. 11, 18126 (2021).","journal-title":"Sci. Rep."},{"key":"25242_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-021-03426-1","volume":"593","author":"NG Davies","year":"2021","unstructured":"Davies, N. G. et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature 593, 270\u2013274 (2021).","journal-title":"Nature"},{"key":"25242_CR15","unstructured":"Meng, B. et al. Recurrent emergence of SARS-CoV-2 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7. Cell Rep. 35, (2021)."},{"key":"25242_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jiph.2021.12.011","volume":"15","author":"PD Yadav","year":"2022","unstructured":"Yadav, P. D. et al. Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers. J. Infect. Public Health 15, 182\u2013186 (2022).","journal-title":"J. Infect. Public Health"},{"key":"25242_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biology12091267","author":"M Andre","year":"2023","unstructured":"Andre, M. et al. From alpha to omicron: How different variants of concern of the SARS-coronavirus-2 \u0131mpacted the world. Biology https:\/\/doi.org\/10.3390\/biology12091267 (2023).","journal-title":"Biology"},{"key":"25242_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41467-022-28324-6","volume":"13","author":"JW Saville","year":"2022","unstructured":"Saville, J. W. et al. Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants. Nat. Commun. 13, 742 (2022).","journal-title":"Nat. Commun."},{"key":"25242_CR19","doi-asserted-by":"publisher","DOI":"10.1140\/epjp\/s13360-021-02321-y","author":"A Gowrisankar","year":"2022","unstructured":"Gowrisankar, A., Priyanka, T. M. C. & Banerjee, S. Omicron: A mysterious variant of concern. Eur. Phys. J. Plus https:\/\/doi.org\/10.1140\/epjp\/s13360-021-02321-y (2022).","journal-title":"Eur. Phys. J. Plus"},{"key":"25242_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27643","author":"D Tian","year":"2022","unstructured":"Tian, D., Sun, Y., Xu, H. & Ye, Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.27643 (2022).","journal-title":"J. Med. Virol."},{"key":"25242_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127204","author":"R Rana","year":"2022","unstructured":"Rana, R., Kant, R., Huirem, R. S., Bohra, D. & Ganguly, N. K. Omicron variant: Current insights and future directions. Microbiol. Res. https:\/\/doi.org\/10.1016\/j.micres.2022.127204 (2022).","journal-title":"Microbiol. Res."},{"key":"25242_CR22","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297923010066","author":"D Sruthi","year":"2023","unstructured":"Sruthi, D. et al. Curative potential of high-value phytochemicals on COVID-19 \u0131nfection. Biochemistry https:\/\/doi.org\/10.1134\/S0006297923010066 (2023).","journal-title":"Biochemistry"},{"key":"25242_CR23","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673334173241003060139","author":"T Sevimoglu","year":"2024","unstructured":"Sevimoglu, T. Implementation of an automated system using machine learning models to accelerate the process of in silico identification of small molecules as drug candidates. Curr. Med. Chem. https:\/\/doi.org\/10.2174\/0109298673334173241003060139 (2024).","journal-title":"Curr. Med. Chem."},{"key":"25242_CR24","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s11030-022-10580-9","volume":"27","author":"RK Chinnadurai","year":"2023","unstructured":"Chinnadurai, R. K. et al. Pharmacoinformatic approach to identify potential phytochemicals against SARS-CoV-2 spike receptor-binding domain in native and variants of concern. Mol. Divers. 27, 2741\u20132766 (2023).","journal-title":"Mol. Divers."},{"key":"25242_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"25242_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1471-2105-10-168","volume":"10","author":"V Le Guilloux","year":"2009","unstructured":"Le Guilloux, V., Schmidtke, P. & Tuffery, P. Fpocket: An open source platform for ligand pocket detection. BMC Bioinform. 10, 168 (2009).","journal-title":"BMC Bioinform."},{"key":"25242_CR27","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"25242_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"25242_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2176924","author":"S Alkilani","year":"2023","unstructured":"Alkilani, S. & Sevimoglu, T. In silico analysis of substitution mutations in the \u03b2-globin gene in Turkish population of \u03b2-thalassemia. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2176924 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"25242_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.109245","volume":"183","author":"S Moradi","year":"2024","unstructured":"Moradi, S. et al. A review on description dynamics and conformational changes of proteins using combination of principal component analysis and molecular dynamics simulation. Comput. Biol. Med. 183, 109245 (2024).","journal-title":"Comput. Biol. Med."},{"key":"25242_CR31","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181, 894\u2013904 (2020).","journal-title":"Cell"},{"key":"25242_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.788972","author":"DP O\u2019Math\u00fana","year":"2022","unstructured":"O\u2019Math\u00fana, D. P. Ivermectin and the \u0131ntegrity of healthcare evidence during COVID-19. Front. Public Health https:\/\/doi.org\/10.3389\/fpubh.2022.788972 (2022).","journal-title":"Front. Public Health"},{"key":"25242_CR33","doi-asserted-by":"publisher","first-page":"6903","DOI":"10.1039\/D3CP03492E","volume":"26","author":"N Wu","year":"2024","unstructured":"Wu, N. et al. Elucidation of protein-ligand interactions by multiple trajectory analysis methods. Phys. Chem. Chem. Phys. 26, 6903\u20136915 (2024).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"25242_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.704205","author":"C Chakraborty","year":"2021","unstructured":"Chakraborty, C., Sharma, A. R., Bhattacharya, M., Agoramoorthy, G. & Lee, S. S. The drug repurposing for COVID-19 Clinical trials provide very effective therapeutic combinations: Lessons learned from major clinical studies. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.704205 (2021).","journal-title":"Front. Pharmacol."},{"key":"25242_CR35","doi-asserted-by":"publisher","first-page":"198915","DOI":"10.1016\/j.virusres.2022.198915","volume":"321","author":"X Hu","year":"2022","unstructured":"Hu, X. et al. Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening. Virus Res. 321, 198915 (2022).","journal-title":"Virus Res."},{"key":"25242_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00418-x","author":"CB Jackson","year":"2022","unstructured":"Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. https:\/\/doi.org\/10.1038\/s41580-021-00418-x (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"25242_CR37","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1021\/acs.jcim.1c00560","volume":"61","author":"B Jawad","year":"2021","unstructured":"Jawad, B., Adhikari, P., Podgornik, R. & Ching, W. Y. Key \u0131nteracting residues between RBD of SARS-CoV-2 and ACE2 receptor: Combination of molecular dynamics simulation and density functional calculation. J. Chem. Inf. Model. 61, 4425\u20134441 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"25242_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221\u2013224 (2020).","journal-title":"Nature"},{"key":"25242_CR39","doi-asserted-by":"crossref","unstructured":"Chaccour, C. et al. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine 32, (2021).","DOI":"10.1016\/j.eclinm.2020.100720"},{"key":"25242_CR40","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jama.2023.1650","volume":"329","author":"S Naggie","year":"2023","unstructured":"Naggie, S. et al. Effect of higher-dose \u0131vermectin for 6 days vs placebo on time to sustained recovery in outpatients with COVID-19: A randomized clinical trial. JAMA 329, 888\u2013897 (2023).","journal-title":"JAMA"},{"key":"25242_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24152751","author":"S Mlala","year":"2019","unstructured":"Mlala, S., Oyedeji, A. O., Gondwe, M. & Oyedeji, O. O. Ursolic acid and \u0131ts derivatives as bioactive agents. Molecules https:\/\/doi.org\/10.3390\/molecules24152751 (2019).","journal-title":"Molecules"},{"key":"25242_CR42","doi-asserted-by":"crossref","unstructured":"Gossen, K. R., Zhang, M., Nikolov, Z. L., Fernando, S. D. & King, M. D. Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin. Sci. Rep. 14, (2024).","DOI":"10.1038\/s41598-024-53086-0"},{"key":"25242_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41429-021-00491-6","author":"AK Zaidi","year":"2022","unstructured":"Zaidi, A. K. & Dehgani-Mobaraki, P. The mechanisms of action of ivermectin against SARS-CoV-2\u2014An extensive review. J. Antibiot. https:\/\/doi.org\/10.1038\/s41429-021-00491-6 (2022).","journal-title":"J. Antibiot."},{"key":"25242_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-020-00368-w","author":"K Sharun","year":"2020","unstructured":"Sharun, K. et al. Ivermectin, a new candidate therapeutic against SARS-CoV-2\/COVID-19. Annals Clin. Microbiol. Antimicrob. https:\/\/doi.org\/10.1186\/s12941-020-00368-w (2020).","journal-title":"Annals Clin. Microbiol. Antimicrob."},{"key":"25242_CR45","doi-asserted-by":"publisher","first-page":"1597609","DOI":"10.3389\/fntpr.2025.1597609","volume":"4","author":"TK Milugo","year":"2025","unstructured":"Milugo, T. K., Owuor, B., Okanya, P. W., Chepukosi, K. & Obiero, G. F. Natural compounds from ethno-medicinal plants exhibit multiple binding activities on SARS-CoV-2 spike protein receptor-binding domains. Front. Nat. Prod. 4, 1597609 (2025).","journal-title":"Front. Nat. Prod."},{"key":"25242_CR46","doi-asserted-by":"publisher","first-page":"2222196","DOI":"10.1080\/13102818.2023.2222196","volume":"37","author":"T Corbo","year":"2023","unstructured":"Corbo, T. et al. Inhibitory potential of phytochemicals on five SARS-CoV-2 proteins: in silico evaluation of endemic plants of Bosnia and Herzegovina. Biotechnol. Biotechnol. Equip. 37, 2222196 (2023).","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"25242_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/09205063.2024.2399395","volume":"36","author":"K Saravanan","year":"2025","unstructured":"Saravanan, K. et al. Targeting SARS-CoV2 spike glycoprotein: molecular insights into phytocompounds binding interactions\u2013in-silico molecular docking. J. Biomater. Sci. Polym. Ed. 36, 315\u2013332 (2025).","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"25242_CR48","doi-asserted-by":"publisher","first-page":"115941","DOI":"10.1016\/j.celrep.2025.115941","volume":"44","author":"Z Feng","year":"2025","unstructured":"Feng, Z. et al. Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein. Cell Rep. 44, 115941 (2025).","journal-title":"Cell Rep."},{"key":"25242_CR49","doi-asserted-by":"publisher","first-page":"7712","DOI":"10.1021\/acs.jcim.5c00990","volume":"65","author":"Y Ferreira e Silva","year":"2025","unstructured":"Ferreira e Silva, Y., Fokoue, H. H. & Batista, P. R. Exploring the Intrinsic structural plasticity and conformational dynamics of human beta coronavirus spike glycoproteins. J. Chem. Inf. Model. 65, 7712\u20137733 (2025).","journal-title":"J. Chem. Inf. Model."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25242-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25242-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25242-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:42:47Z","timestamp":1761810167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25242-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25242"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25242-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37927"}}